Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
73.63
+3.78 (5.41%)
At close: May 12, 2025, 4:00 PM
73.63
0.00 (0.00%)
After-hours: May 12, 2025, 4:01 PM EDT
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $5.29 billion as of May 12, 2025. Its market cap has increased by 22.81% in one year.
Market Cap
5.29B
Enterprise Value
4.21B
1-Year Change
22.81%
Ranking
Category
Stock Price
$73.63
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $5.29B, an increase of 564.26%. That is a compound annual growth rate of 65.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 5.02B | -9.82% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |